Reckitt's CEO Unexpectedly Quits After Three Years At The Helm

Reckitt's CEO Laxman Narasimhan will leave the company at the end of September motivated by a desire to return to the US. Company director Nicandro Durante will take the reins on an interim basis while the UK-based health and hygiene giant seeks a long-term replacement.

ReckittBenckiser
• Source: Shutterstock

Reckitt Benckiser Group plc CEO Laxman Narasimhan has resigned unexpectedly to take on the equivalent role at coffee chain Starbucks Corporation.

More from Leadership

US FDA Retirements Continue Unabated With Drug Inspectorate Leaders, Former Chief Counsel

 

Alonza Cruse, director of the Office of Human and Animal Drugs Inspectorate, and two other senior inspection officials are departing, along with Mark Raza, chief counsel from 2021 until January.

FDA Leadership Shuffle Continues: Lowell Zeta Returns As OPDP, OGD Leaders Depart

 

Lowell Zeta, a senior counselor at the FDA from 2020 to 2021, returns as deputy commissioner for strategic initiatives. The agency also names a new acting CIO and acting CVM director, but OGD's Ted Sherwood and OPDP's Catherine Gray retired.

Over The Counter: Brands, Brexit And New Self-Care Business Models, With PAGB’s Michelle Riddalls

 
• By 

HBW Insight catches up with UK OTC industry association CEO Michelle Riddalls to talk about digital self-care and the unrealized promise of Brexit - part 2.

Makary Suggests Combining All FDA Adverse Event Reporting Systems

 

In discussing FDA’s adverse event monitoring, Makary also seemed to falsely imply the agency did not fully investigate the myocarditis signal with COVID-19 vaccines.

More from HBW Insight